Vivo Capital as of Sept. 30, 2016
Portfolio Holdings for Vivo Capital
Vivo Capital holds 22 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 33.5 | $107M | 4.2M | 25.61 | |
| Ascendis Pharma A S (ASND) | 11.1 | $36M | 1.8M | 20.10 | |
| Eiger Biopharmaceuticals | 7.5 | $24M | 1.8M | 13.39 | |
| Codexis (CDXS) | 7.3 | $24M | 5.3M | 4.44 | |
| Nabriva Therapeutics | 6.9 | $22M | 3.2M | 7.05 | |
| Advanced Accelerat spon ads each rep 2 ord | 5.4 | $17M | 456k | 38.08 | |
| Agile Therapeutics | 4.4 | $14M | 2.0M | 6.98 | |
| Regenxbio Inc equity us cm (RGNX) | 4.3 | $14M | 990k | 14.01 | |
| Trevena | 3.6 | $12M | 1.7M | 6.75 | |
| Aimmune Therapeutics | 3.6 | $11M | 763k | 15.00 | |
| Colucid Pharmaceuticals | 2.7 | $8.6M | 225k | 38.15 | |
| Foamix Pharmaceuticals | 2.5 | $7.9M | 855k | 9.26 | |
| Capnia | 2.1 | $6.7M | 7.5M | 0.90 | |
| Akari Therapeutics | 1.4 | $4.5M | 528k | 8.51 | |
| Pronai Therapeutics | 1.4 | $4.4M | 2.4M | 1.82 | |
| Dynavax Technologies (DVAX) | 1.2 | $3.8M | 360k | 10.49 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.6 | $1.9M | 4.2M | 0.46 | |
| Revance Therapeutics | 0.4 | $1.3M | 77k | 16.21 | |
| Ocera Therapeutics | 0.1 | $405k | 153k | 2.64 | |
| Capnia Inc Common Stock Warrants | 0.1 | $198k | 944k | 0.21 | |
| Palatin Technologies | 0.1 | $148k | 235k | 0.63 | |
| Zosano Pharma | 0.0 | $78k | 99k | 0.79 |
